MARKET

GRTX

GRTX

Galera Therapeutics, Inc.
OTCMQB
0.100
0.000
0.00%
Closed 12:59 05/15 EDT
OPEN
0.100
PREV CLOSE
0.100
HIGH
0.105
LOW
0.100
VOLUME
20.84K
TURNOVER
2.09K
52 WEEK HIGH
0.150
52 WEEK LOW
0.015
MARKET CAP
16.04M
P/E (TTM)
0.155
1D
5D
1M
3M
1Y
5Y
1D
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
TipRanks · 1d ago
Galera Therapeutics bylaws grant shareholders right to act by written consent
PUBT · 1d ago
Galera Therapeutics Q1 EPS $(0.01), Same YoY
Benzinga · 2d ago
Galera net loss widens to $1.61 million in Q1 2026
PUBT · 2d ago
Galera Shareholders Approve Governance Changes and Share Increase
TipRanks · 5d ago
Galera Therapeutics shareholders approve reverse stock split authorization range 1-for-75 to 1-for-200
PUBT · 5d ago
Weekly Report: what happened at GRTX last week (0504-0508)?
Weekly Report · 5d ago
Galera Therapeutics files Form 3 beneficial ownership statement for Emerald Bioventures LLC
PUBT · 05/04 21:58
More
About GRTX
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.

Webull offers Galera Therapeutics Inc stock information, including OTCMQB: GRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRTX stock methods without spending real money on the virtual paper trading platform.